Literature DB >> 23791708

An introduction to statistical process control in research proteomics.

David Bramwell1.   

Abstract

BACKGROUND: Statistical process control is a well-established and respected method which provides a general purpose, and consistent framework for monitoring and improving the quality of a process. It is routinely used in many industries where the quality of final products is critical and is often required in clinical diagnostic laboratories [1,2]. To date, the methodology has been little utilised in research proteomics. It has been shown to be capable of delivering quantitative QC procedures for qualitative clinical assays [3] making it an ideal methodology to apply to this area of biological research.
OBJECTIVE: To introduce statistical process control as an objective strategy for quality control and show how it could be used to benefit proteomics researchers and enhance the quality of the results they generate.
RESULTS: We demonstrate that rules which provide basic quality control are easy to derive and implement and could have a major impact on data quality for many studies.
CONCLUSIONS: Statistical process control is a powerful tool for investigating and improving proteomics research work-flows. The process of characterising measurement systems and defining control rules forces the exploration of key questions that can lead to significant improvements in performance. BIOLOGICAL SIGNIFICANCE: This work asserts that QC is essential to proteomics discovery experiments. Every experimenter must know the current capabilities of their measurement system and have an objective means for tracking and ensuring that performance. Proteomic analysis work-flows are complicated and multi-variate. QC is critical for clinical chemistry measurements and huge strides have been made in ensuring the quality and validity of results in clinical biochemistry labs. This work introduces some of these QC concepts and works to bridge their use from single analyte QC to applications in multi-analyte systems. This article is part of a Special Issue entitled: Standardization and Quality Control in Proteomics.
Copyright © 2013 The Author. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-DE; Control chart; FN; FP; False negative; False positive; LC–MS; QC; Quality control; Quantitative proteomics; SPC; Statistical process control; TN; TP; True negative; True positive; VSN; Variance Stabilisation Normalisation

Mesh:

Year:  2013        PMID: 23791708     DOI: 10.1016/j.jprot.2013.06.010

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  8 in total

1.  MSstatsQC: Longitudinal System Suitability Monitoring and Quality Control for Targeted Proteomic Experiments.

Authors:  Eralp Dogu; Sara Mohammad-Taheri; Susan E Abbatiello; Michael S Bereman; Brendan MacLean; Birgit Schilling; Olga Vitek
Journal:  Mol Cell Proteomics       Date:  2017-05-08       Impact factor: 5.911

Review 2.  Protein biomarkers for subtyping breast cancer and implications for future research.

Authors:  Claudius Mueller; Amanda Haymond; Justin B Davis; Alexa Williams; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2018-01-03       Impact factor: 3.940

3.  An Automated Pipeline to Monitor System Performance in Liquid Chromatography-Tandem Mass Spectrometry Proteomic Experiments.

Authors:  Michael S Bereman; Joshua Beri; Vagisha Sharma; Cory Nathe; Josh Eckels; Brendan MacLean; Michael J MacCoss
Journal:  J Proteome Res       Date:  2016-10-04       Impact factor: 4.466

Review 4.  Optimizing Mass Spectrometry Analyses: A Tailored Review on the Utility of Design of Experiments.

Authors:  Elizabeth S Hecht; Ann L Oberg; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-07       Impact factor: 3.109

5.  Implementation of statistical process control for proteomic experiments via LC MS/MS.

Authors:  Michael S Bereman; Richard Johnson; James Bollinger; Yuval Boss; Nick Shulman; Brendan MacLean; Andrew N Hoofnagle; Michael J MacCoss
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-05       Impact factor: 3.109

6.  Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.

Authors:  Maria Frantzi; Akshay Bhat; Agnieszka Latosinska
Journal:  Clin Transl Med       Date:  2014-03-29

7.  Signatures for mass spectrometry data quality.

Authors:  Brett G Amidan; Daniel J Orton; Brian L Lamarche; Matthew E Monroe; Ronald J Moore; Alexander M Venzin; Richard D Smith; Landon H Sego; Mark F Tardiff; Samuel H Payne
Journal:  J Proteome Res       Date:  2014-03-24       Impact factor: 4.466

8.  QCloud: A cloud-based quality control system for mass spectrometry-based proteomics laboratories.

Authors:  Cristina Chiva; Roger Olivella; Eva Borràs; Guadalupe Espadas; Olga Pastor; Amanda Solé; Eduard Sabidó
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.